glp 1 and eating disorders GLP-1RAs Obesity Associated with Tips for prescribing GLP-1s in
Description
In a recent clinical study, individuals with heart failure and preserved ejection fraction who received weekly semaglutide injections (2.4 mg) for 52 weeks experienced substantially improved symptoms and physical function compared to the placebo group 9
Conclusion Research into GLP-1 alcohol use reduction is an exciting frontier that intersects metabolic and addiction science
10.1016/j.diabres.2013.12.041
No large-scale studies have evaluated microdosing specifically
